Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 435, 879 (16 June 2005) | doi:10.1038/435879a; Published online 15 June 2005
No longer the upstart
Abstract
The US biotechnology industry's lobby shop is at last making its mark. Its incoming president may have taken some flak for quitting Congress but, as Meredith Wadman discovers, he's relishing the change.
When the Biotechnology Industry Organization (BIO) held its first annual meeting in Raleigh, North Carolina, in 1993, the new trade group's leaders were thrilled to fill a hotel with 1,400 attendees. Next week, BIO expects to host 18,000 people at its annual convention in Philadelphia, filling the Pennsylvania Convention Center and 28 nearby hotels with people from 4,600 companies and 55 countries.
To read this story in full you will need to login or make a payment (see right).